Hospital Group Wants Trump Administration to Block a New Lilly Policy on 340B Claims Data

Hospital group wants Trump administration to block a new Lilly policy on 340B claims data

The American Hospital Association is asking the Trump administration to stop Eli Lilly from enacting a new policy that would require all hospitals that participate in a federal drug discount program to submit comprehensive claims data, the first time that a large pharmaceutical company has taken such a step. The new Lilly policy, which is slated to go into effect on Feb. 1, expands on an earlier move to reduce its costs for selling medicines to …

Large Hospital Group Asks HRSA to Immediately Block Lilly’s 340B In-House Pharmacy Claims Data Policy - 340B Report

The American Hospital Association (AHA) on Monday asked federal regulators to “take any and all available enforcement action” to halt drugmaker Eli Lilly’s proposed policy that would require covered entities to submit claims data on 340B drugs dispensed through in-house pharmacies.

AHA urges HRSA to stop Eli Lilly’s 340B claims-data submission policy from going into effect

The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and Company policy from taking effect on Feb. 1, including by “assessing civil monetary penalties for intentionally overcharging 340B hospitals.”   On Jan. 15, Lilly issued a notice to all 340B covered entities that the company was updating its data requirements for its 340B distribution program. The policy would require 340B c…